Evidence map›Paper›PMID 42783980›Full record

ArticleJournal of fungi (Basel, Switzerland)2026

Localized Cutaneous Versus Deep Sporotrichosis at Hospital das Clínicas, UFMG, Belo Horizonte, Brazil: A Cohort of 213 Culture-Confirmed Cases, 2011 to 2026.

Helena Duani, Frederico Figueiredo Amâncio, Alexandre Soares Bifano, Vitória Baltazar Mattos, Kaique Veloso Silva, Beatriz Vieira Melo, Heloisa Filipe Pascoal, Rafael Lima Sendin, Marcus Vinicius Carvalho Akerman, Felipe Torreão Corrêa Thiemann and 5 more

Abstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Helena DuaniInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0000-0001-9345-018X
Frederico Figueiredo AmâncioInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0000-0002-5732-7173
Alexandre Soares BifanoPostgraduate Program in Infectious Diseases and Tropical Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0007-7580-7334
Vitória Baltazar MattosInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0008-9847-9625
Kaique Veloso SilvaInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0006-1458-2269
Beatriz Vieira MeloInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0003-4821-4489
Heloisa Filipe PascoalInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0009-3058-037X
Rafael Lima SendinInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0002-2921-8049
Marcus Vinicius Carvalho AkermanInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0005-1697-623X
Felipe Torreão Corrêa ThiemannInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0004-9431-9406
Giulia Bravim GonçalvesInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0009-0009-9263-6631
Adriana Cristina Camargos de RezendePostgraduate Program in Infectious Diseases and Tropical Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0000-0001-8585-984X
Leandro Cesar da SilvaSanta Casa de Patrocínio, Patrocínio 38740-000, Minas Gerais, Brazil.ORCID 0009-0002-7797-6709
Shinfay Maximilian LiuMicrobiology Laboratory, Hospital das Clínicas, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.ORCID 0000-0003-3683-5109
Marise Oliveira FonsecaInfectious Diseases Service, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, UFMG, Belo Horizonte 30130-100, Minas Gerais, Brazil.

Funding

Conselho Nacional de Desenvolvimento Científico e TecnológicoFundação de Amparo à Pesquisa do Estado de Minas Gerais
6 · The paper itself

Abstract

backgroundThe zoonotic epidemic of sporotrichosis caused by

methodsThe study involves a retrospective observational cohort of patients with sporotrichosis treated at a quaternary university hospital in Belo Horizonte between 2011 and 2026, restricted to culture-positive cases. Localized cutaneous disease was compared with deep infection using logistic regression adjusted for age and sex.

resultsOf 313 patients, 213 had a positive culture. The median age was 41 years, and 54.0% were women. Lymphocutaneous disease predominated (54.0%), and contact with cats was reported by 53.1%. The median treatment duration was 150 days. Among the 101 patients with a defined outcome, 97 were cured (96.0%), with no documented treatment failure. All four sporotrichosis-related deaths occurred in the deep infection group, which was independently associated with comorbidity (OR 9.69; 95% CI 2.52 to 37.23) and an immunosuppressive condition (OR 6.61; 95% CI 1.89 to 23.09).

conclusionsLocalized cutaneous sporotrichosis was cured in nearly all the patients with documented follow-up, whereas mortality was confined to deep infection associated with comorbidities and immunosuppression.

Indexed as

Brazilcohortimplantation mycosisitraconazoleSporothrix brasiliensissporotrichosis

Identifiers

PMID42783980
PMCPMC13608755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.